Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2022

May 17, 2022

34129_dirs_2022-05-17_32f0bcde-4442-40c9-8e04-c91eda39bafd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2022-05-14

Reporting Person: Bonvini Ezio (Sr VP, Research & CSO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-05-14 Common Stock M 5000 Acquired 116090 Direct
2022-05-14 Common Stock F 1666 $4.16 Disposed 114424 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-05-14 Restricted Stock Unit $0.0 M 5000 Disposed Common Stock (5000.0) Direct

Footnotes

F1: On May 14, 2020, the reporting person was granted 10,000 restricted stock units, 50% of which vested on May 14, 2021 and 50% of which vested on May 14, 2022. Restricted stock units convert into the Company's common stock on a one-for-one basis